SCD1 is overexpressed in various cancer types, including breast, prostate, and liver cancers. Increased SCD1 activity is associated with enhanced lipid metabolism, cell proliferation, and resistance to apoptosis, making it an attractive target for cancer therapy.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
3-Pyridazinecarbonyl chloride, 1,6-dihydro-6-oxo- (9CI)
